Altered bile acid metabolism; significant inflammation and host metabolic disorders as a result of activation of bacterial fermentation; altered hepatic lipogenesis, gluconeogenesis and glycogenolysis in an Ahr-dependent manner. This evidence concerns the gene AHR and metabolic disease.